Akintunde “Tunde” Bello
Senior Vice President, Head of Clinical Pharmacology, Pharmacometrics, and Bioanalysis, Bristol Myers Squibb
Tunde Bello is a member of the American Society for Clinical Pharmacology and Therapeutics, the American Association of Pharmaceutical Scientists, and the American Society for Clinical Oncology. He joined BMS in 1998, before moving to Pfizer in 2003 as clinical pharmacology group leader. He returned to BMS in 2015 and today holds key responsibilities for the development, approval, and lifecycle management of numerous marketed drugs.
“I am inspired by the progress we continue to make in the development of new medicines and therapies that are more tailored to the needs of our patients. I am also inspired by the privilege of working with talented drug developers across a wide range of functions, all working on the common goal of bringing new treatments to patients.”
Read our interview with Tunde Bello
Read our article on diversity with Tunde Bello
